Nov 05, 2024 / 09:30PM GMT
Operator
Thank you for standing by. At this time, I'd like to welcome everyone to the Cytek Biosciences Third Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to rejoin your question again, press the star one. I will now turn the conference over to Paul Goodson, Head of Investor Relations. Paul, please go ahead.
Paul Goodson - Cytek Biosciences, Inc. - Head of Investor Relations
Thank you, operator. Earlier today, Cytek Biosciences released financial results for the quarter ended September 30th, 2024. If you have not received this news release or if you'd like to be added to the company's distribution list, please send an email to [email protected]. Joining me today from Cytek are Wenbin Jiang, CEO; and William McCombe, CFO.
Before we begin, I'd like to remind you that management will
Q3 2024 Cytek Biosciences Inc Earnings Call Transcript
Nov 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers